Skip to content
Vol. IV · Issue III · 08 May 2026 N 40°42′47″ · W 74°00′21″ Cal. 2026-05-07 14:32 UTC · σ 0.61 ● Lab in session
PLATE I Brain Premier (Caputron) · tDCS & Brain Stimulation N 40°42′ · W 74°00′ SCALE 1 : 1 device · N · NEARCTIC
Plate I · tDCS & Brain Stimulation

Brain Premier (Caputron)

Lowest-cost device backed by a reputable tDCS retailer (Caputron) with electrical-safety verification

· Not yet tested
BY · Biohacker Atlas Editorial Team · Editorial collective
PUB ·
WELLNESS

Marketed as a general wellness device. Not FDA cleared, approved, or evaluated for any medical claim.

No subscription
Visit Brain Premier (Caputron) → From $99
Fig. I · Bench readout

Key facts at a glance.

Founded
2019
Headquarters
New York, NY, USA
Price range
$99–$174.99
Pricing as published by the manufacturer Trustpilot · refreshed weekly Bench measurements forthcoming
Fig. II · Cost of ownership

The real price over three years.

Brain Premier (Caputron) · 3-year horizon

Total cost of ownership · 3yr

Hardwareone-time$99
3-year total$99
Hardware · subscription · consumables · energy Year toggle: 1 / 2 / 3 / 5 Per § 3 of the legend
Fig. III · Key features

What the device does.

  • + Most affordable new tDCS device in Caputron lineup
  • + Simple single-dial interface
  • + Safety timer and current limiter
  • + Independently electrical-safety tested
  • + Focus, meditation, and mood use cases
  • + Pre-owned option at $99
Fig. IV · Strengths & weaknesses

The trade-offs.

↑ Pros
  • + **Lowest-cost device backed by reputable tDCS retailer (Caputron)**
  • + **Electrical-safety verification** via Caputron's clinical-grade infrastructure
  • + $99-174.99 entry-tier accessible pricing
  • + 2019-founded with established Caputron retailer credibility
↓ Cons
  • General-wellness positioning (no specific FDA clearance like Caputron ActivaDose's iontophoresis)
  • Lower-tier vs Caputron ActivaDose flagship ($249-449 with off-label FDA-cleared chassis)
  • Brand identity overlap with Caputron creates evaluation confusion
  • Limited consumer-experience signal documentation
Fig. V · Best for

Budget-conscious consumers seeking entry-level reliable tDCS

Fig. VI · Editorial review

The long read.

§ Hands-on instrument testing pending. Based on published specifications and third-party data.

Overview

Brain Premier (Caputron) is the lowest-cost tDCS device backed by reputable retailer with electrical-safety verification specialist — founded 2019 in NYC under Caputron’s broader ecosystem, with structural value claim built on Caputron retailer credibility + electrical-safety verification + $99-174.99 entry-tier accessible pricing. For cost-priority buyers wanting Caputron-backed safety verification at lower price than ActivaDose flagship, Brain Premier is structurally distinctive.

The structural editorial caveats: general-wellness positioning vs Caputron ActivaDose’s off-label-FDA-cleared iontophoresis chassis, lower-tier vs ActivaDose flagship ($249-449), and brand identity overlap with Caputron creates evaluation confusion.

When Brain Premier Makes Sense

Strong fit: Cost-priority within Caputron retailer ecosystem; entry-tier tDCS exploration with safety verification; sub-$200 budget within reputable-retailer-backed tier.

Weaker fit: Off-label FDA-cleared chassis (Caputron ActivaDose); FDA-PMA depression treatment (Flow Neuroscience FL-100); EU prescribed depression (Sooma); idiot-proof entry (TheBrainDriver V2.1).

3-Year Cost of Ownership

Use caseCost
Brain Premier (Caputron)~$99-174.99

Compare: TheBrainDriver V2.1 ($127-150), Caputron ActivaDose ($249-449 off-label cleared), Flow Neuroscience FL-100 ($400+ FDA PMA), foc.us V3 ($188-399).

Brain Premier (Caputron) earns a recommended verdict on lowest-cost tDCS device backed by reputable retailer (Caputron) with electrical-safety verification, $99-174.99 entry-tier accessible pricing, and 2019-founded established Caputron retailer credibility — balanced against general-wellness positioning vs ActivaDose off-label clearance, lower-tier vs Caputron flagship, brand identity overlap, and limited consumer-experience signal.

For cost-priority within Caputron retailer ecosystem + entry-tier tDCS with safety verification, structurally appropriate. For off-label FDA-cleared chassis (ActivaDose), FDA-PMA depression treatment (Flow Neuroscience), or idiot-proof entry (TheBrainDriver V2.1), alternatives are better matched.

Changelog

  • 2026-05-07: Initial review published based on Brain Premier (Caputron) published specifications.
Fig. VII · Hands-on protocol on file

What we'll measure on the bench.

Protocol
Multimeter at electrodes (current source verification)
Primary metric
Output current at each preset (mA)
Pass threshold
within ±10% of selected current
Session shape
3 measurements per preset × all presets

§ Bench session pending. Measured values will replace this panel as the protocol completes — see Plate VI · Methodology for the full testing rulebook.

← Back to tDCS & Brain Stimulation territory